Article
Phosphorylation switches Bax from promoting to inhibiting apoptosis thereby increasing drug resistance.
EMBO reports - 1 Sept 2018
Kale Justin, Kutuk Ozgur, Brito Glauber Costa, Andrews Tallulah S, Leber Brian, Letai Anthony, Andrews David W
Abstract excerpt
Akt is a pro-survival kinase frequently activated in human cancers and is associated with more aggressive tumors that resist therapy. Here, we connect Akt pathway activation to reduced sensitivity to chemotherapy via Akt phosphorylation of Bax at residue S184, one of the pro-apoptotic Bcl-2 family proteins required for cells to undergo apoptosis. We show that phosphorylation by Akt converts the pro-apoptotic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
